Recommendations for selecting and sequencing therapies used to treat patients with relapsing multiple sclerosis.
ALS-Related Biomarkers Remain Unchanged With PrimeC Combination Treatment
Awareness of Botulinum Toxins in the Movement Disorder Landscape: Laxman Bahroo, DO
Pioneering Care for Autoimmune Disorders Through Research and Results: The Mayo Clinic Way
NeuroVoices: Heidi Schambra, MD, on Expanding Capabilities of Stroke Rehabilitation With the PrimSeq Digital Tool